Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
(Adnkronos) – VIENNA, June 12, 2023 /PRNewswire/ — Croma-Pharma® (‘Croma’) announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid
